Phosphorylation of Eukaryotic Elongation Factor 2 Can Be Regulated by Phosphoinositide 3-Kinase in the Early Stages of Myoblast Differentiation

참고문헌 (Reference)

1 Canicio, J, "p70 S6 kinase activation is not required for insulinlike growth factor-induced differentiation of rat, mouse, or human skeletal muscle cells." 139 : 5042-5049, 1998

2 Parker, S. B, "p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells." 267 : 1024-1026, 1995

3 Zhang, P, "p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step." 13 : 213-224, 1999

4 Olson, E. N, "bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out." 8 : 1-8, 1994

5 Pinset, C, "Wortmannin inhibits IGF-dependent differentiation in the mouse myogenic cell line C2." 320 : 367-374, 1997

6 Cortright, D. N, "Vanadate stimulation of 2-deoxyglucose transport is not mediated by PI3-kinase in human skeletal muscle." 1358 : 300-306, 1997

7 Hay, N, "Upstream and downstream of mTOR." 18 : 1926-1945, 2004

8 Ryazanov, A. G, "Translational Regulation Gene Expression" Plenum Press, New York. 433-455, 1993

9 Rameh, L. E, "The role of phosphoinositide kinase lipid products in cell function." 274 : 8347-8350, 1999

10 Waga, S, "The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA." 369 : 574-578, 1994

11 Coolican, S. A, "The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways." 272 : 6653-6662, 1997

12 Jeon, Y. J, "The 100-kDa protein, whose phosphorylation precedes the fusion of chick embryonic myoblasts, is the eukaryotic elongation factor-2." 198 : 132-137, 1994

13 Fingar, D. C, "Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression." 23 : 3151-3171, 2004

14 Cuenda, A, "Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis." 274 : 4341-4346, 1999

15 Browne, G. J, "Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor-2 kinase and to its phosphorylation at a novel site, serine 398." 279 : 2004

16 Kim, H. S, "Sphingosine blocks both membrane fusion and calmodulin-dependent phosphorylation of the 100-kDa protein of chick embryonic myoblasts." 205 : 408-411, 1993

17 Giorgino, F, "Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulin-like Lanahan, A., Williams, J. B., Sanders, L. K., and Nathans, D. growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells." 272 : 7455-7463, 1997

18 Gao, N, "Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer." 310 : 1124-1132, 2003

19 Shin, Y. J, "Retinoic acid and its geometrical isomers block both growth and fusion of L6 myoblasts by modulating the expression of protein kinase A." 10 : 162-168, 2000

20 Yao, R, "Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor." 267 : 2003-2006, 1995

21 Lassar, A. B, "Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal." 6 : 788-794, 1994

22 Wang, X, "Regulation of elongation factor 2 kinase cyclins by p90 (RSK1) and p70 S6 kinase." 20 : 4370-4379, 2001

23 Palfrey, H. C, "Rapid activation of calmodulin-dependent protein kinase III in mitogen-stimulated human fibroblasts. Correlation with intracellular Ca transients." 262 : 9785-9792, 1987

24 Zieve, G. W, "Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells." 2 : 397-405, 1980

25 Nilsson, A, "Phosphorylation of eukaryotic elongation factor 2 in differentiating and proliferating HL-60 cells." 1268 : 263-268, 1995

26 Ryazanov, A. G.,, "Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation." 334 : 170-173, 1988

27 Valius, M, "Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor’s mitogenic signal." 73 : 321-334, 1993

28 Kaliman, P, "Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells." 271 : 1996

29 Quelle, D. E.,, "Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts." 7 : 1559-1571, 1993

30 Kimura, K, "Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase." 269 : 1994

31 Jiang, B. H, "Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B." 96 : 2077-2081, 1999

32 Shu, L, "Myogenic differentiation is dependent on both the kinase function and the Nterminal sequence of mammalian target of rapamycin." 277 : 2002

33 Guo, K, "MyoD-induced expression of p21 inhibits cyclindependent kinase activity upon myocytes terminal differentiation." 15 : 3823-3829, 1995

34 Ryazanov, A. G, "Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to catalyze translocation." 251 : 187-190, 1989

35 Woo, J. H, "Lipid products of phosphoinositide 3-kinase abrogate genistein- induced fusion inhibition in myoblasts." 529 : 84-94, 2006

36 Sarker, K. P, "L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway." 23 : 6064-6070, 2004

37 Kaliman, P, "Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells." 12 : 66-77, 1998

38 Foulstone, E. J, "Insulin-like growth factor (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis." 189 : 207-215, 2001

39 Conejo, R, "Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities." 86 : 82-94, 2001

40 De Angelis, L, "Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm." 95 : 1998

41 Thomas, J. E, "Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase." 64 : 182-195, 1997

42 Miyatake, S, "Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas." 182 : 401-408, 1995

43 Nairn, A. C, "Identification of calmodulin-dependent protein kinase III and its major Mr 100,000 substrate in mammalian tissues." 82 : 7939-7943, 1985

44 Florini, J. R, "Growth hormone and the insulin-like growth factor system in myogenesis." 17 : 481-517, 1996

45 Lanahan, A, "Growth factor-induced delayed early response genes." 12 : 3919-3929, 1992

46 Musgrove, E. A.,, "Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression." 13 : 3577-3587, 1993

47 Casagrande, F, "G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY294002 is correlated to upregulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells." 422 : 385-390, 1998

48 Kiess, M, "Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation." 6 : 1287-1298, 1995

49 Okada, T, "Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin." 269 : 3568-3573, 1994

50 Ryazanov, A. G, "Elongation factor-2 kinase and its newly discovered relatives." 514 : 26-29, 2002

51 Lavoie, J. N.,, "Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway." 271 : 1996

52 Muise-Helmericks, R. C, "Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway." 273 : 1998

53 Baek, H. J, "Cyclic AMP negatively modulates both Ca2+/calmodulin-dependent phosphorylation of the 100-kDa protein and membrane fusion of chick embryonic myoblasts." 165 : 178-184, 1994

54 Gutzkow, K. B, "Cyclic AMP inhibits translation of cyclin D3 in T lymphocytes at the level of elongation by inducing eEF2-phosphorylation." 15 : 871-881, 2003

55 Halevy, O, "Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD." 267 : 1018-1024, 1995

56 Tuazon, P. T, "Comparative analysis of phosphorylation of translational initiation and elongation factors by seven protein kinases." 264 : 2773-2777, 1989

57 Nadal-Ginard, B, "Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis." 15 : 855-864, 1978

58 Matsushime, H, "Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle." 65 : 701-713, 1991

59 Laemmli, U. K, "Cleavage of structural proteins during the assembly of the head of bacteriophage T4." 227 : 680-685, 1970

60 Patel, J, "Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors." 269 : 3076-3085, 2002

61 Kim, H. S, "Ca2+/calmodulin-dependent phosphorylation of the 100-kDa protein in chick embryonic muscle cells in culture." 150 : 223-230, 1992

62 Watts, C. K, "Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells." 31 : 95-105, 1994

63 Knebel, A, "A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta." 20 : 4360-4369, 2001

64 Altucci, L, "17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrest human breast cancer cells." 12 : 2315-2324, 1996